COMPLEMENT ACTIVATION AND BIOINCOMPATIBIUTY: The terminal complement complex for evaluation and surface modification with heparin for Improvement of biomaterials

Clinical & Experimental Immunology

Volumn 86, Issue , 1991, Pages 21-26

  Mollnes, T E ^a   Videm, V ^a   Riesenfeld, J ^b   Garred, P ^a   Svennevig, J L ^a   Fosse, E ^a   Hogasen, K ^a   Harboe, M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Carmeda AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEXTRAN SULFATE; HEPARIN; LAMINARAN; POLYETHYLENE DERIVATIVE; POLYSACCHARIDE; POLYVINYLCHLORIDE; BIOMATERIAL;

ARTICLE; CHEMISTRY; COMPLEMENT ACTIVATION; HUMAN; IN VITRO STUDY; MATERIALS TESTING; METABOLISM; OXYGENATOR; CONFERENCE PAPER; PRIORITY JOURNAL;

COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEXTRAN SULFATE; HEPARIN; HUMANS; MATERIALS TESTING; OXYGENATORS; OXYGENATORS, MEMBRANE; POLYETHYLENES; POLYSACCHARIDES; POLYVINYL CHLORIDE;

EID: 0026039737     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1991.tb06202.x     Document Type: Article

References (37)

1. Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary Bypass
2. Relative inefficiency of terminal complement activation.